25 May 2013
Keywords: Cipla, Meditab, M&A
Article | 27 August 2010
India’s third largest drugmaker Cipla (BSE: 500087) says that its board has approved the acquisition of fellow India based Meditab ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.